BIOMAT Database Logo BIOMAT Database Logo

Factor VIII inhibitors development following introduction of B-domain-deleted recombinant factor VIII in four hemophilia A previously treated patients. 2003

V Roussel-Robert, and M F Torchet, and F Legrand, and C Rothschild, and N Stieltjes

UI MeSH Term Description Entries
D007518 Isoantibodies Antibodies from an individual that react with ISOANTIGENS of another individual of the same species. Alloantibodies
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody

Related Publications

V Roussel-Robert, and M F Torchet, and F Legrand, and C Rothschild, and N Stieltjes
Clinical evaluation of B-domain deleted recombinant factor VIII in previously treated patients.
April 2001, Seminars in hematology,
V Roussel-Robert, and M F Torchet, and F Legrand, and C Rothschild, and N Stieltjes
Clinical evaluation of B-domain deleted recombinant factor VIII in previously untreated patients.
April 2001, Seminars in hematology,
V Roussel-Robert, and M F Torchet, and F Legrand, and C Rothschild, and N Stieltjes
Efficacy and inhibitor development in previously treated patients with haemophilia A switched to a B domain-deleted recombinant factor VIII.
August 2004, British journal of haematology,
V Roussel-Robert, and M F Torchet, and F Legrand, and C Rothschild, and N Stieltjes
Recombinant, B-domain deleted factor VIII (r-VIII SQ): pharmacokinetics and initial safety aspects in hemophilia A patients.
February 1997, Thrombosis and haemostasis,
V Roussel-Robert, and M F Torchet, and F Legrand, and C Rothschild, and N Stieltjes
Second generation, B-domain deleted recombinant factor VIII.
July 1997, Thrombosis and haemostasis,
V Roussel-Robert, and M F Torchet, and F Legrand, and C Rothschild, and N Stieltjes
Measurement of factor VIII activity of B-domain deleted recombinant factor VIII.
April 2001, Seminars in hematology,
V Roussel-Robert, and M F Torchet, and F Legrand, and C Rothschild, and N Stieltjes
Viral safety of B-domain deleted recombinant factor VIII.
April 2001, Seminars in hematology,
V Roussel-Robert, and M F Torchet, and F Legrand, and C Rothschild, and N Stieltjes
Efficacy and inhibitor development in previously treated patients with haemophilia A switched to a B domain-deleted recombinant factor VIII - clarification of Kogenate inhibitor data.
July 2005, British journal of haematology,
V Roussel-Robert, and M F Torchet, and F Legrand, and C Rothschild, and N Stieltjes
B-domain deleted recombinant factor VIII formulation and stability.
April 2001, Seminars in hematology,
V Roussel-Robert, and M F Torchet, and F Legrand, and C Rothschild, and N Stieltjes
Comparative immunogenicity of recombinant B domain-deleted porcine factor VIII and Hyate:C in hemophilia A mice presensitized to human factor VIII.
April 2004, Journal of thrombosis and haemostasis : JTH,
Copied contents to your clipboard!